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Various follow-up studies of children hospitalized with bronchiolitis caused by respiratory syncytial virus have
demonstrated that a significant proportion of infants (50%) have recurrent wheezing during childhood. Nevertheless, the
relationship between these two entities, if any, has not been established. In order to explain this observation, several
hypotheses have been proposed. The first suggests that some children could have an individual predisposition to bronchiolitis
caused by respiratory syncytial virus and recurrent wheezing. The virus could be a marker of this condition, and the
individual predisposition could in turn be related to an individual hypersensitivity to common allergens (atopy), airway
hyperreactivity, or to some disorder related to pulmonary anatomy or physiology that was present before the acute episode
of bronchiolitis. Another hypothesis proposes that respiratory syncytial virus could be directly responsible for recurrent
wheezing. During an episode of bronchiolitis, the damage in the airway mucosa caused by the vital inflammatory response
to infection contributes to sensitivity to other allergens or exposes irritant receptors, resulting in recurrent wheezing. For
this review, we analyzed the studies that discuss these hypotheses with the purpose of clarifying the mechanisms for the
important issue of recurrent wheezing in childhood.
DESCRIPTORS: Respiratory Syncytial Virus. Respiratory Tract Infections. Acute Bronchiolitis. Recurrent
Wheezing. Literature Review.
INTRODUCTION
Studies performed in children hos-
pitalized with bronchiolitis due to res-
piratory syncytial virus (RSV) have
shown that about 50% of these have
episodes of recurrent wheezing. These
episodes disappeared on average by 3
to 4 years of age1-7.
The high frequency with which
such a clinical course occurs suggests
that there is a relationship between the
two phenomena. However, the nature
of this relationship is not known. The
question is whether RSV is responsi-
ble for this clinical course or is merely
the marker of a predisposition to have
wheezing crises.
The interest in clarifying this ques-
tion lies in the possible therapeutic or
prophylactic implications. If RSV bron-
chiolitis leads to the recurrent wheez-
ing, this would justify research into the
use of therapeutics that could decrease
the inflammatory process and thereby
contribute to the avoidance of subse-
quent wheezing. Studies that explore
the use of corticoid therapy or sodium
cromoglycate soon after the acute phase
of bronchiolitis fall into this category8.
On the other hand, if RSV can be used
as a marker of children who will present
recurrent wheezing, precocious identi-
fication of these patients would enable
appropriate attendance and counseling.
Many researchers have been working
on this theme with the objective of
identifying risk factors and decreasing
morbidity.
The present work offers a review of
the literature registered in Index
Medicus and Latin-American Index
Medicus over the last 25 years,
through the databases of MEDLINE
CD ROM and LILACS CD ROM. All
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of the studies published in English and
Spanish were analyzed. The studies
considered relevant for the analysis of
bronchiolitis and recurrent wheezing
involved children with confirmed in-
fection due to RSV and without prior
episodes of wheezing or any preexist-
ing pathology. Therefore, those stud-
ies that evaluated the course of chil-
dren presenting their first episode of
wheezing without demonstration of
the virus were excluded.
RSV BRONCHIOLITIS AND
RECURRENT WHEEZING
The most significant works that
evaluated sequels in children with
RSV bronchiolitis are summarized in
Table 1. All of the studies were obser-
vational and had similar methodolo-
gies, in which hospitalized children
were followed up or reevaluated with
systematic research of the anomalies.
The hospitalization criterion selected
a population of more seriously ill pa-
tients with a greater possibility of se-
quels. In this context, it was demons-
trated that 42% to 71% of the children
admitted with RSV bronchiolitis expe-
rienced recurrent wheezing up to 6 to
10 years of age. Except for the work
by Sims et al.1, the studies demon-
strated alterations in pulmonary func-
tion tests that persisted many years af-
ter bronchiolitis, and the authors that
researched bronchial lability after ex-
ercise or histamine/methacholine pro-
vocative testing also found an altered
response in relation to the controls.
None of the studies statistically
analyzed the correlation of the occur-
rence of recurrent wheezing with the
subgroup of the virus.
Regarding the cases of bronchioli-
tis that are not hospitalized, Stein et
al. carried out a prospective study in
which infants with disease of the lower
respiratory tract before age 3, due to
various etiological agents, were fol-
lowed up until age 13. The children
infected with RSV had a 3 to 4 times
greater chance of presenting recurrent
wheezing by age 6 compared to the
controls. Risk decreased markedly
with age and was not significant by
age 13. A similar tendency was ob-
served in disease of the lower respira-
tory tract due to other agents (influ-
enza, adenovirus, rhinovirus, cytome-
galovirus, chlamydia, bacteria, and
mixed infections), but this was less
consistent than when due to RSV. A
higher chance of recurrent wheezing
was not detected among children with
disease due to parainfluenza viruses9.
Consequently, the studies demon-
strated that there is an association be-
tween RSV bronchiolitis and recurrent
wheezing. This association does not
depend on the gravity of the infection,
since although more hospitalized chil-
dren were studied, it was also demon-
strated in patients treated in ambula-
tory settings. Hypotheses suggested to
explain this association include:
1 - Severe respiratory infection – bron-
chiolitis as a clinical manifestation
of RSV infection – occurs because
the individual has a predisposi-
tion, which is responsible for the
subsequent symptoms;
2 - The viral infection in an early
phase of life causes damage to the
immature lung or alters the im-
mune response, thereby contribut-
ing directly to the recurrent wheez-
ing.
In the first case, RSV bronchiolitis
would be merely indicative of the pre-
existing condition; in the second case,
there would be a cause and effect rela-
tionship. Still a third possibility would
involve the sum of the above two fac-
tors.
ANALYZING THE FIRST
HYPOTHESIS
Most infants are exposed to RSV
and present an upper respiratory tract
illness. However, approximately 25%
to 40% of these infants present bron-
chiolitis10. The following predisposing
conditions could determine this differ-
ence in the response and also the de-
velopment of recurrent wheezing:
1 - Hypersensitivity to common aller-
gens (atopy);
2 - Airway hyperreactivity;
3 - Anatomic or physiological lung al-
terations.
1 – Hypersensitivity to common
allergens
Atopy is a preexistent condition
defined by hypersensitivity to common
allergens; among other mechanisms,
the individual presents an IgE-medi-
ated response when in contact with
certain agents11. This immune response
could occur in response to the pres-
ence of the RSV itself, generating an
airway inflammatory response, similar
to that which occurs in asthma. Later,
by virtue of the same predisposition,
the individual presents wheezing cri-
ses when in contact with other agents.
Type I hypersensitivity reaction in
RSV bronchiolitis
Type I hypersensitivity reaction
classically occurs following the first
contact with the antigen, with conse-
quent production of specific IgE and
few clinical manifestations. Thus, sub-
sequent contact results in the inflam-
matory reaction, since the activation of
mast cells and basophils by the IgE
linked to the antigen leads to the re-
lease of mediators responsible for the
inflammatory infiltrate, after which the
symptoms become relevant11.
There is no epidemiological evi-
dence of prior exposure to RSV among
children with bronchiolitis12,13. How-
ever, in some cases during sympto-
matic infection, the production of
RSV-specific IgE has been demon-
strated, especially among infants with
wheezing14,15-19.
Mast cell and basophil activation
has been demonstrated through the
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products they release: histamine in the
nasopharyngeal secretions of the in-
fants infected by RSV17,20 and tryptase
concentration (a mast cell-specific
product), in bronchoalveolar lavage21.
In addition, leukotriene C-4 (LTC4)
was found more frequently in the na-
sopharyngeal secretion of children
with wheezing, and the concentrations
were 5-fold higher than in children
with upper airway illness. Leukotriene
C-4 is a potent bronchoconstrictor and
inductor of mucus secretion, and in
addition, produces an increase in vas-
cular permeability and induces pulmo-
nary edema22. Leukotriene C-4 was de-
tected in 83% of the children with
RSV-specific IgE in the nasopharynx
and 24% of the children without RSV-
specific IgE (P <0.001)23.
Among the mediators released by
the mast cells and basophils are eosi-
nophil chemotactic factors. The pres-
ence of eosinophils in the lower air-
ways during RSV infection is not well
clarified, but the eosinophilic cationic
protein (ECP) concentration that is re-
leased by them indirectly indicates
their participation. Eosinophilic cati-
onic protein concentration in children
with RSV bronchiolitis was signifi-
cantly higher than the ECP concentra-
tion in both groups of children with
RSV upper respiratory illness and
groups with RSV pneumonia without
wheezing24.
Table 1 - Summary of the main findings from follow-up studies of children with bronchiolitis due to respiratory syncytial
virus isolated in 100% of cases (all necessitated hospitalization).
Principal author, Type of study Parameters analyzed Results Exposure to Correlation
Date Number of patients cigarette smoke with atopy
followed up
Sims1, 1978 Case-control Wheezing 50% in cases
35 cases 3% controls
8 years PFT NS NS NS
Bronchial lability Greater than
after exercise in controls
Pullan2, 1982 Case-control Wheezing 42% cases and
130 cases 19% of controls Greater exposure
10 years PFT Altered in in cases compared NS
all indices  to control group
Lability after 16% of cases
exercise 5% controls
Histamine 19% of cases
provocative testing 7% controls
Hall3, 1984 Prospective Wheezing 45% after 4 years
25 cases and 20% after
8 years 8 years 76% of cases NS
PFT FEV1/FVC and
PEFR normal
↓ FEF25-75 and
Vmax25
Sly4, 1989 Prospective Wheezing 71% of cases
35 cases Spirometry ↓ in 12% of cases
6 years Histamine 84% of cases 86% of cases NA
provocative testing
Welliver5,6 Prospective Wheezing 60% in 5 years
1993 43 cases 30% in 8 years
7-8 years
PFT FEF25-75
and FEF50 Correlated with Correlated with
60% to 80% of reduced small reduced large
the expected values airway function airway function
Methacoline 70% of cases and
provocative testing 11% of controls
Sigurs 7, 1995 Prospective, Wheezing 60% of cases 32% of cases
case-control 32% of controls NS 9% of controls
47 cases
3 years
NS – not statistically significant; NA – not analyzed; PFT – pulmonary function testing; PEFR – peak expiratory flow rate; VEF1/FVC –
forced expiratory volume in 1 second / forced vital capacity; FEF 25-75 – forced expiratory flow at 25% to 75% of vital capacity; FEF50 –
forced expiratory flow at 50% of vital capacity; Vmax 25 – maximum expiratory flow when 25% of the forced vital capacity has been
expired.
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In short, there is evidence that an
IgE-mediated reaction occurs in RSV
infections, including detection of
RSV-specific IgE in the nasopharynx
of 50% to 65% of patients and indi-
rect data indicating the participation
of basophils, mast cells, and
eosinophils, namely the concentra-
tions of histamine, tryptase, and me-
diators such as LTC4 and ECP. These
elements in general have a higher pres-
ence in wheezing illness, and some are
linked to greater gravity. Infants with
pneumonia without wheezing and who
also have an intense inflammatory
process present smaller amounts of IgE
and histamine than children with
wheezing, indicating that the greater
quantity of these factors is not related
to the degree of inflammation alone,
but are in fact a component of hyper-
sensitivity14,17,21,23,24.
Not all of the episodes of bronchi-
olitis are accompanied by detection of
these factors. This could be due to
technical difficulties or to participa-
tion of this reaction only in predis-
posed individuals. It should be remem-
bered that IgE-mediated hypersensitiv-
ity reaction is not the only patho-
genetic mechanism of bronchiolitis.
Hence, there are other factors involved
in its pathogenesis25.
The relationship between RSV bron-
chiolitis and atopy
Demonstration of atopy among in-
fants with RSV bronchiolitis would re-
veal a preexistent condition responsi-
ble for the bronchiolitis and recurrent
wheezing. The presence of manifesta-
tions such as allergic rhinitis, atopic
dermatitis, and asthma, in addition to
sensitization against common environ-
mental antigens and eosinophilia, are
found in atopic individuals11. These
phenomena have been investigated in
children with RSV bronchiolitis.
The findings of the various studies
on this theme are controversial (Table
1). In general, an association has not
been confirmed between RSV bronchi-
olitis and the presence of atopy; in
other words, it seems that atopy is not
a predisposing condition for the devel-
opment of bronchiolitis2,3,7. With re-
gard to recurrent wheezing, in a lon-
gitudinal study, Stein et al. demon-
strated that the association between
RSV and increased risk of recurrent
wheezing was independent of an aller-
gic sensitization 9.
However, in other studies, atopic
children apparently had a higher
chance of experiencing recurrent
wheezing following RSV bronchioli-
tis than nonatopic children1,26. Based
on this, some authors have tried to
identify a marker related to atopy that
appears during bronchiolitis and that
can predict which children will de-
velop recurrent wheezing. The re-
searchers measured RSV-specific IgE,
number of eosinophils in the acute
phase of the disease, ECP in nasal se-
cretions, and myeloperoxidase, and
then correlated these with the clinical
course5,27,28,29. However, to date, no
study has been conclusive. Neverthe-
less, there are indications that RSV-
specific IgE could be this marker.
Welliver et al. have demonstrated that
infants with high levels of RSV-spe-
cific IgE at the time of the RSV infec-
tion present a 70% chance of recurrent
wheezing by age 4 and that undetec-
table RSV-specific IgE is associated
with a 80% chance of no recurrence5.
Eosinophilia during the acute phase of
the infection, although it has low sen-
sitivity (27%), demonstrated a speci-
ficity of 75% to 94% in predicting re-
current wheezing27,28.
2 – Airway hyperreactivity
Another preexistent condition is
related to the airway hyperreactivity to
nonspecific stimulus. This hyper-
reactivity is demonstrated through al-
terations in pulmonary function test-
ing after inhalation of substances such
as methacholine, histamine, and cold
air or stimuli such as physical exer-
cise30-32. This reactivity appears to de-
crease with age, such that the hista-
mine or methacholine doses necessary
to produce a bronchial provocation
tests response in children are many
times smaller than those necessary to
stimulate adults33. Likewise, normal
adults do not present alteration in pul-
monary function after cold air inhala-
tion. It is speculated that underlying
enhanced airway reactivity is present
in some children from birth and that
loss of reactivity is part of the normal
development and lung maturation
process34.
Once RSV involves the infant’s
lungs, a marked reactivity could be
triggered, thereby explaining the oc-
currence of bronchiolitis. Other com-
mon viral infections in this phase of
life could lead to subsequent wheez-
ing until lung maturation is reached
and the reactivity decreases. At
present, this is just a hypothesis, since
there are no studies demonstrating that
infants with RSV bronchiolitis had air-
way hyperreactivity prior to the epi-
sode. All of the studies found altera-
tions in the bronchial provocation
tests after bronchiolitis (Table 1).
3 – Anatomic physiological lung al-
teration
Finally, some anatomic physiologi-
cal airway alterations, such as narrow-
ing for instance, could lead to dimin-
ished lung function, which though
without clinical manifestation, could
mean that the individual is at increased
risk for obstruction with viral infec-
tions. These would be “transitory
wheezers” in which recurrent wheez-
ing would cease by age 4 to 5 years,
as their airways increase in size or as
airway-parenchymal interactions
change34. This possibility is strongly
supported by Martinez et al. who per-
formed pulmonary function testing on
124 children before 6 months of age
before any lower respiratory tract ill-
43
Bronchiolitis, respiratory syncytial virus, and recurrent wheezing
Fonseca C de B et al.
REV. HOSP. CLÍN. FAC. MED. S. PAULO 58(1):39-48, 2003
ness had developed. They then fol-
lowed these infants through the first
year of life and studied the incidence
and characteristics of lower respiratory
tract illness among them. In the case
of boys, the lower conductance values
corresponded to a 10-fold greater
chance of presenting wheezing com-
pared to infants with higher values.
This alteration could reflect narrower
airways. For girls, the higher risk of
wheezing (16-fold greater chance) was
linked to a decrease in the functional
residual capacity (FRC), reflecting a
smaller size of the lungs35. Therefore,
children of both sexes can be predis-
posed to wheezing, but due to differ-
ent aspects of the pulmonary function.
A study has yet to be performed us-
ing appropriate specific methodology
for children with RSV bronchiolitis and
measurement of prior lung function.
ANALYZING THE SECOND
HYPOTHESIS
The possibility that RSV infection
causes recurrent wheezing would have
the following mechanism: during a
bronchiolitis episode, damage to the
respiratory mucosa due to the intense
inflammatory process, especially in the
most severe disease, would facilitate
sensitization by other allergens or
would provoke an exposure of irritant
receptors, resulting in the recurrent
wheezing36.
The available studies were per-
formed in experimental models or in
vitro using human lymphocytes. Re-
garding the favoring or accentuation
of atopy, it was demonstrated that ani-
mals infected with RSV present greater
sensitization when exposed to aller-
gens such as pollen and ovalbumin
than noninfected animals. Similarly,
while studying lymphocytes of infants
after RSV infection, greater sensiti-
zation was demonstrated against
Dermatophagoides farinae, α-casein,
and ovalbumin compared to a group
that suffered infection due to other
agents37-40.
Experimental models have also
demonstrated that there is induction of
airway hyperreactivity to provocation
testing after RSV bronchiolitis, which
can normalize with time41,42. The virus
causes acute and chronic changes in
neural control of airways in animal
models. Specifically, after experimen-
tal RSV infection, there is an increase
in the contraction mediated by the
cholinergic and nonadrenergic, non-
cholinergic excitatory (NANCe) path-
way, as well as a decrease in broncho-
dilation mediated by a nonadrenergic,
noncholinergic inhibitory (NANCi)
pathway 43.
Furthermore, there appears to be an
interaction between the sensitization
and the hyperreactivity after RSV
bronchiolitis. Animals sensitized by
ovalbumin inhalation prior to RSV in-
fection present an increase in the pul-
monary resistance to provocation test-
ing with acetylcholine on day 6 of the
infection and markedly greater histo-
logical pulmonary damage than ani-
mals that had RSV infection alone or
were only sensitized to ovalbumin44. It
has been suggested that a preexistent
allergic state can lead to hyper-
reactivity that is associated with
greater epithelial damage during RSV
infection45.
These studies suggest that RSV
bronchiolitis can favor sensitization
against other allergens. But it still has
not been possible to establish a rela-
tionship between these experiments
and clinical findings. As mentioned
above, we did not find a constantly
greater incidence of atopy among the
children that had bronchiolitis. Maybe
this mechanism is important in produc-
ing an enhancement of the atopy in
atopic children, but it does not seem
that the RSV itself induces the atopy.
On the other hand, there is better cor-
relation of experimental and clinical
studies regarding the hyperreactivity
after bronchiolitis, because this is veri-
fied in many children who had bron-
chiolitis. It is possible that the viral in-
fection can only delay pulmonary
maturation in terms of the improve-
ment in the airway reactivity with the
age, since the risk of wheezing de-
creases markedly during childhood9,34.
Whatever the case, it is difficult to
interpret the relationship between an
event that occurred in infancy and al-
terations demonstrated years later.
Many other factors can interfere in pul-
monary function over time, such as
pollution, exposure to cigarette smoke
and other irritants, or sensitization to
various allergens that are not always
detected by the common tests3,46,47. As
summarized in table 1, exposure to
cigarette smoke was greater in the
bronchiolitis cases than among the
controls, thereby constituting a confus-
ing factor in the interpretation of the
relationship between RSV bronchioli-
tis and recurrent wheezing. The recur-
rence of the inflammatory process it-
self, whatever the triggering factor, can
contribute to the alteration of pulmo-
nary function.
CONCLUSIONS
- Children hospitalized for RSV
bronchiolitis have, on average, a 50%
chance of presenting recurrent wheez-
ing. Therefore, families should be
counseled regarding the possibility of
undergoing a special follow-up. Since
symptoms tend to disappear with time,
excessive diagnostic investigations are
unnecessary.
- Recurrent wheezing in the
child with RSV bronchiolitis can be
related to factors present prior to the
bronchiolitis, such as atopy, airway
hyperreactivity, or an anatomic physi-
ological alteration of the airways (less
conductance or lower functional re-
sidual capacity (FRC)). Furthermore,
experimental studies suggest that
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lower-airway damage provoked by
RSV can alter the course of bronchial
hyperreactivity and enhance atopy,
thereby enabling the sensitization
against other allergens or alteration of
the pulmonary function.
- Both these hypotheses that
have been presented to explain the re-
lationship between RSV bronchiolitis
and recurrent wheezing are possible.
The most probable is that there are dif-
ferent groups of children in which
each of the alterations may be present,
including an interrelationship between
them. The effects caused by the virus
would be dependent on each of the
conditions presented by the host.
Manifestation of these alterations can
also be related to exposure to environ-
mental factors. The following figure
summarizes these possibilities.
PERSPECTIVES
The pathogenesis of bronchiolitis
is not fully understood. This review
concentrated on those aspects related
to IgE-mediated immunity because
their relationship with recurrent
wheezing has been studied most. As
already mentioned, the determination
of a marker that appears during bron-
chiolitis and that could be predictive
of which children will present recurrent
wheezing would be very useful during
the follow up of these patients. Re-
searchers have been working in this
area, and the results regarding RSV-
specific IgE are promising.
Within the same field, the use of
corticoids for the treatment of bronchi-
olitis or recurrent wheezing prevention
is frequently studied. However, the use
of corticoids remains controversial, and
the conflicting results are mainly due
to inadequate methodology of the stud-
ies8. It is possible that this therapeutic
approach would be beneficial for a spe-
cific group of children that react with
production of RSV-specific IgE. To con-
firm this possibility, case-control stud-
ies would be necessary in children with
RSV bronchiolitis without chronic dis-
ease or previous wheezing, identifying
those who produce RSV-specific IgE or
not and selecting them to receive or not
receive corticoid therapy during and af-
ter bronchiolitis. These patients would
then have to be followed up prospec-
tively to determine the risk of presen-
ting recurrent wheezing.
Regarding other aspects of the hu-
moral immunity, it is known that al-
though infection by RSV does not in-
duce definitive immunity, high titers
of RSV- specific IgG protect against
the occurrence of bronchiolitis by re-
stricting the infection to the upper air-
ways. Thus, the use of gamma-globu-
lin for the prophylaxis of bronchioli-
tis, although not in current use prima-
rily because of its high cost, would
contribute to avoiding the occurrence
of recurrent wheezing. Its use at present
is restricted to children with risk fac-
tors for severe disease due to RSV.
There are no studies regarding the im-
pact of this management in the infant
population in general. Likewise, the
production of a vaccine that stimulates
the production of antibodies could
also contribute to prophylaxys 25.
With regard to cellular immunity,
although this is the main factor re-
sponsible for viral clearance, its acti-
vation between 5 and 7 day of the dis-
ease coincides with the worsening of
the symptoms. In other words, the
lymphocytes responsible for eliminat-
ing the virus can contribute to the
damage of the respiratory mucosa. Be-
fore interfering with the cellular immu-
nity process, more study is needed to
understand and evaluate the delicate
balance between protection and dam-
age production25.
The treatment of bronchiolitis with
ribavirin has been analyzed as an in-
tervention that can reduce the chance
of recurrent wheezing. However, as yet
there has been no conclusive study, the
question remains controversial48,49.
Finally, attempts to classify chil-
dren according to progression of the
wheezing and its pathophysiological
condition facilitate an understanding
of the morbid process and allow for
better management and potentially for
reduced morbidity. This is one of the
objectives of research that is dedicated
to the study of bronchial asthma. It has
been suggested that there are 3 distinct
phenotypes among wheezing infants,
reflecting a heterogeneous group of
conditions, whose common final path-
way is recurrent airway obstruction:
(1) “transient early wheezing” in
which the associated condition would
be a reduced pulmonary function that
Figure 1 - Respiratory syncytial virus bronchiolitis and recurrent wheezing.
RSV: Respiratory syncytial virus; RW: Recurrent wheezing; FRC: Functional residual capacity.
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resolves by age 3; (2) “nonatopic
wheezing” characterized by disap-
pearance of the symptoms by age 13
and nonallergic sensitization, with vi-
ral infection as the common cause of
obstruction of the airways, especially
due to RSV; and (3) “atopic wheezing/
asthma” that progresses with the clas-
sic form of persistent asthma. These
groups were defined in longitudinal
studies, after many years of follow-up
of wheezing children50.
How to determine prospectively
which group each child will belong to
after RSV bronchiolitis remains to be
discovered. Furthermore, it is necessary
to continue this follow-up and to re-
view this classification, since even
those individuals that improve with age
can become symptomatic in adult life42.
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RESUMO
FONSECA C de B e col. - A bron-
quiolite pelo virus sincicial respi-
ratório e o chiado recorrente: qual
a relação? Rev. Hosp. Clín. Fac.
Med. S. Paulo 58(1):39-48, 2003.
Os diversos estudos de seguimen-
to de crianças hospitalizadas por
bronquiolite pelo virus sincicial respi-
ratório demonstram, em média, 50%
de chance de evoluir com novos epi-
sódios de chiado no peito. Apesar des-
ta constatação, não foi estabelecida a
relação entre a bronquiolite pelo virus
sincicial respiratório e a recorrência
dos episódios de chiado. A primeira
hipótese é de que o indivíduo poderia
ter uma predisposição para a repetição
do quadro de chiado e também para a
própria bronquiolite como manifesta-
ção da infecção pelo virus sincicial
respiratório. O vírus seria um marcador
desta condição. Esta predisposição
pode estar relacionada a uma hiper-
sensibilidade a alérgenos comuns
(atopia), hiper-reatividade a estímulos
não específicos ou alguma alteração
pulmonar anátomo-fisiológica presen-
tes antes da bronquiolite.
Outra hipótese é a de que o virus
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sincicial respiratório é o responsável
por esta evolução. Durante um episó-
dio de bronquiolite, a lesão da mucosa
respiratória decorrente do intenso pro-
cesso inflamatório, principalmente nos
quadros mais graves, facilitaria a
sensibilização para outros alérgenos
ou provocaria uma exposição de recep-
tores para irritantes, resultando nos
quadros de chiado recorrentes.
Nesta revisão, os autores analisam
as pesquisas que sustentam essas hipó-
teses com o objetivo de sistematizar o
conhecimento sobre este assunto e
apresentá-lo de forma organizada, como
uma contribuição à compreensão da
recorrência dos episódios de chiado.
DESCRITORES: Vírus sincicial
respiratório. Infecções respiratórias.
Bronquiolite aguda. Chiado recor-
rente. Revisão da literatura.
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